Annovis Bio, Inc. (ANVS) stock
ANVSNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.93+0.08 (+9.31%)
Close on Nov 13, 2026Market cap $39.46MP/E –Yield –
Annovis Bio enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Annovis Bio's enterprise value was $17.63M on Nov 11, 2026, against $87.67M a year earlier. Over the last 5 years it ranged from $10.52M to $162.17M, with a median of $60.29M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $17.63M | -67.7% |
| 2025 | Dec 31, 2025 | $54.56M | +0.7% |
| 2024 | Dec 31, 2024 | $54.18M | -66.6% |
| 2023 | Dec 29, 2023 | $162.17M | +108.8% |
| 2022 | Dec 30, 2022 | $77.65M | -18.2% |
| 2021 | Dec 31, 2021 | $94.95M | +121.0% |
| 2020 | Dec 31, 2020 | $42.97M | – |
See a number that looks wrong?